Marc Blaustein serves as Executive at Finch Therapeutics Group, Inc., where they oversee executive responsibilities. Since joining the company, Marc Blaustein has executed 3 insider transactions totaling $6.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 21, 2023 involved selling 4,619 shares valued at $1.8K.
Marc Blaustein currently holds 27,995 shares of Finch Therapeutics Group, Inc. (FNCH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Blaustein has been a net seller of FNCH stock. They have purchased $0 and sold $6.8K worth of shares.
Marc Blaustein's most recent insider trade was on Feb 21, 2023, when they sold 4,619 shares at $0.38 per share.
Get notified when new Form 4 filings are submitted
| $1.39 |
| Discretionary |
| Jun 13, 2022 | FNCH | $0 | Award | 35,000 | $N/A | Discretionary |